DD
Daniel Patrick O'Day (Chairman & CEO) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $19.7M of GILD (112,429 sh across 2 lots, as filed), executed Nov 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
15
0 buys · 15 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$76.2M
shares × price, as filed
Last traded
Nov 5
Filed Nov 6
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $82.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
15 filings
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$19.7M112,429 sh across 2 lots
Exec Nov 4
Filed Nov 6 · 5:15 PM ET GILDSALE Gilead Sciences, Inc. View filing → $5.3M
30,881 sh across 6 lots
Exec Oct 30
Filed Nov 2 · 7:14 PM ET GILDSALE Gilead Sciences, Inc. View filing → $2.2M
15,000 sh across 2 lots
Exec Oct 1
Filed Oct 2 · 4:40 PM ET GILDSALE Gilead Sciences, Inc. View filing → $2.2M
15,000 sh across 3 lots
Exec Sep 1
Filed Sep 2 · 4:12 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.9M
14,400 sh across 2 lots
Exec Aug 3
Filed Aug 4 · 5:40 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.9M
15,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 4:14 PM ET GILDSALE Gilead Sciences, Inc. View filing → $2.0M
15,000 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.3M
10,000 sh across 2 lots
Exec Apr 28
Filed Apr 29 · 5:30 PM ET More filings →